A microscopy image of Leptospira bacteria. Image credit: Wunder et al. (CC BY 4.0)
A potential vaccine protects hamsters and mice against death caused by multiple Leptospira species, and prevents kidney colonisation in mice.
Scientists have designed a single-dose universal vaccine that could protect against the many forms of leptospirosis bacteria, according to a study published today in eLife.
An effective vaccine would help prevent the life-threatening conditions caused by leptospirosis, such as Weil’s disease and lung haemorrhage, which are fatal in 10% and 50% of cases, respectively.
Leptospirosis is caused by a diverse group of spirochetes called leptospires. A broad range of mammals, including rats, harbour the bacteria in their kidneys and release them into the environment through their urine. Humans and animals can then get infected after coming into contact with contaminated water or soil. In addition to having a major impact on the health of vulnerable human populations, leptospirosis is an economically important animal health problem, making it a significant One Health challenge. This means that collaborative efforts are needed across disciplines and sectors to improve public health outcomes against leptospirosis infection.
The Leptospira family of bacteria is made up of 64 species with 300 different varieties (called serovars). This makes developing a vaccine challenging, because researchers need to find a common feature of the bacteria that will trigger an immune response.
“We have recently identified a novel protein called FcpA in the flagella of Leptospira which enables it to move and penetrate human and animal tissues,” explains first author Elsio Wunder Jr, Associate Research Scientist in Epidemiology (Microbial Diseases) at Yale School of Public Health, Yale University, New Haven, US. “With this study, we wanted to see whether using engineered Leptospira that lacks a functional FcpA molecule has the potential for a vaccine that could provide major public health benefit.”
The mutated FcpA Leptospira was tested as an attenuated vaccine – a live vaccine that cannot cause disease. After the vaccine was given to hamsters and mice, it disseminated throughout the body before being cleared within seven days in the hamsters and after two weeks in the mice. No traces of the mutated Leptospira could be detected in kidney tissue or blood after this time point, showing that the attenuated vaccine is cleared by the immune system before it results in disease or death.
To test whether the vaccine candidate could protect against all types of Leptospira infection, they tested a single dose of the mutant Leptospira and compared this against heat-killed Leptospira to see whether they could prevent infection and disease by a range of similar and different serovars. Immunisation with the heat-killed vaccine gave partial protection against similar serovars but not against different serovars of Leptospira. By contrast, the attenuated vaccine (mutated Leptospira) provided cross-protection against serovars belonging to three different species of Leptospira, which encompass the majority of serovars of importance to human and animal health.
Further analysis of the mice and hamsters after vaccination showed that they generated antibodies that recognised a wide range of proteins across the different species of Leptospira. Moreover, by studying the antibody response in detail, the team identified 41 different proteins that could be targets for future vaccines. The majority of these proteins (70%) looked similar across all 13 disease-causing species of Leptospira studied, suggesting they are likely to be important to the microbes’ survival and would make effective future vaccine candidates.
“In this proof-of-concept study, we have shown that a universal leptospirosis vaccine candidate can prevent both death and kidney colonisation in animal models,” concludes author Albert Ko, Department Chair and Professor of Epidemiology (Microbial Diseases) at Yale School of Public Health. “These findings take us one step closer to achieving the holy grail for the field, which is an effective vaccine that protects against the many Leptospira species and can be deployed as a broad solution to the human and animal health challenge caused by leptospirosis.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Leptospirosis With Pulmonary Hemorrhage, Caused by a New Strain of Serovar Lai: Langkawi
Leptospirosis is an important ubiquitous zoonosis, most common in humid subtropical and tropical regions, caused by pathogenic strains of Leptospira interrogans. Leptospirosis is mainly an ...
- Mumbai’s capacity-building response to COVID-19 has lessons for all cities
In the aftermath of the July 2005 deluge, numerous photos emerged of stranded people wading through Mumbai’s flooded streets.
- Dengue and Leptospirosis in Saint Lucia
Based on epidemiological trends from previous years, the ministry records higher cases of dengue fever during the rainy season.
- Mumbai’s great rat hunt and why it matters to you
Since 2015, leptospirosis has killed 70 people in Mumbai, more than dengue and malaria. It is an uphill battle that the city’s massive rat-killing machinery has been desperately trying to win ...
- Now, leptospirosis a cause for concern
Leptospirosis cases and deaths have spiralled up in all districts in the aftermath of heavy rain and flooding. Even though the Health Department has launched an awareness drive on the efficacy of ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- The cattle sector benefits enormously from a wide array of vaccines
Healthy cattle production relies on good vaccination strategies. The general public is now hearing about efficacy of COVID-19 vaccines, two doses of ...
- State achieves 60% full vaccination coverage
Kerala has achieved 60% full vaccination coverage of its eligible population (above 18 years) against COVID-19, Health Minister Veena George said here in a statement on Friday. The State has so ...
- Increase in reports of dogs infected with Leptospirosis in Massachusetts
Leptospirosis is a disease that can affect ... Dogs, livestock, wildlife and rodents can all spread the disease. There is a vaccine for dogs and the Department of Agricultural Resources recommends ...
- Vet costs for dogs in 25 U.S. cities
The average cost of a single vaccine across these cities—$33.35 ... and parvovirus (DAPP); H3N2 and H3N8 influenza; leptospirosis; Lyme disease; and rabies. The average spaying and neutering ...
- Residents urged to keep pets up to date on rabies
Other common dog vaccines include distemper, canine parvovirus, leptospirosis and adenovirus, Paczosa said. Of course cats should also be vaccinated against rabies, he added, and other common ...